Ledipasvir/Sofosbuvir plus /-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network

被引：0
|
作者：
Curry, Michael P. [1 ]
Bacon, Bruce [2 ]
Dieterich, Douglas T. [3 ]
Guest, Lauren [4 ]
Kowdley, Kris [5 ]
Lee, Yoori [4 ]
Tsai, Naoky [6 ]
Younossi, Zobair [7 ]
Flamm, Steven L. [8 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA
[2] St Louis Univ, Sch Med, Med, St Louis, MO USA
[3] Icahn Sch Med Mt Sinai, Med, New York, NY 10029 USA
[4] Trio Hlth Analyt, La Jolla, CA USA
[5] Swedish Med Ctr, Med, Seattle, WA USA
[6] Univ Hawaii, Queens Med Ctr, Med, Honolulu, HI 96822 USA
[7] Inova Fairfax Hosp, Med, Falls Church, VA USA
[8] Northwestern Univ, Feinberg Sch Med, Med, Chicago, IL 60611 USA
来源：
TRANSPLANTATION | 2016年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-36
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [1] LEDIPASVIR/SOFOSBUVIR ± RIBAVIRIN IN HCV POST-TRANSPLANT PATIENTS: REAL-WORLD HETEROGENEOUS POPULATION FROM THE TRIO NETWORK
    Flamm, S.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Guest, L.
    Kowdley, K.
    Lee, Y.
    Tsai, N.
    Younossi, Z.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S822 - S823
  • [2] Ledipasvir/Sofosbuvir plus /-Ribavirin in Patients Co-infected with HCV and HIV: Real-world Heterogeneous Population from the TRIO Network
    Dieterich, Douglas
    Bacon, Bruce
    Curry, Michael
    Flamm, Steven
    Guest, Lauren
    Kowdley, Kris V.
    Lee, Yoori
    Tsai, Naoky
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2016, 150 (04) : S1041 - S1041
  • [3] LEDIPASVIR/SOFOSBUVIR plus /-RIBAVIRIN IN PATIENTS CO-INFECTED WITH HCVAND HIV: REAL-WORLD HETEROGENEOUS POPULATION FROM THE TRIO NETWORK
    Dieterich, D.
    Bacon, B.
    Curry, M.
    Flamm, S.
    Guest, L.
    Kowdley, K.
    Lee, Y.
    Tsai, N.
    Younossi, Z.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S756 - S757
  • [4] UTILIZATION OF DAA THERAPIES LEDIPASVIR/SOFOSBUVIR AND SOFOSBUVIR/VELPATASVIR IN PATIENTS WITH GENOTYPE 1 HCV: REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK
    Tsai, Naoky
    Bacon, Bruce
    Curry, Michael
    Dieterich, Douglas T.
    Flamm, Steven L.
    Kowdley, Kris V.
    Milligan, Scott
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2017, 152 (05) : S1091 - S1091
  • [5] Utilization of DAA therapies ledipasvir/sofosbuvir and sofosbuvir/velpatasvir in patients with genotype 1 HCV: real-world experience from the TRIO Network
    Tsai, N.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Flamm, S.
    Kowdley, K.
    Milligan, S.
    Younossi, Z.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S726 - S726
  • [6] Real-world experience with sofosbuvir/ribavirin and sofosbuvir-ledipasvir in HIV/HCV-coinfected patients
    McAneny, A.
    Dingwall, S.
    Ramgopal, M.
    Bagwell, D.
    Pierone, G., Jr.
    ANTIVIRAL THERAPY, 2015, 20 : A66 - A67
  • [7] Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets
    Flamm, S.
    Charlton, M.
    Manns, M.
    Prieto, M.
    Fernandez, I.
    Londono, M.
    Kwok, R.
    Smith, C.
    Lee, S.
    Ngo, H.
    Osinusi, A.
    Copans, A.
    Rossaro, L.
    Shoreibah, M.
    Massoud, O.
    Curry, M.
    Bourliere, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 259 - 259
  • [8] Comparison of Sofosbuvir plus /- Simeprevir in Heterogeneous, Real-World Populations of HCV Patients Over 70 Years of Age vs Younger HCV Patients; Data From the TRIO Network
    Tsai, Naoky
    Bacon, Bruce
    Flamm, Steven L.
    Kowdley, Kris
    Lawitz, Eric
    Milligan, Scott
    Younossi, Zobair M.
    Dieterich, Douglas T.
    GASTROENTEROLOGY, 2015, 148 (04) : S1085 - S1085
  • [9] COMPARISON OF SOFOSBUVIR plus /- SIMEPREVIR IN HETEROGENEOUS, REAL-WORLD POPULATIONS OF HCV PATIENTS OVER 70 YEARS OF AGE VS YOUNGER HCV PATIENTS; DATA FROM THE TRIO NETWORK
    Tsai, N.
    Kowdley, K.
    Bacon, B.
    Flamm, S.
    Lawitz, E.
    Milligan, S.
    Younossi, Z.
    Dieterich, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S627 - S627
  • [10] Effectiveness and safety of ledipasvir/sofosbuvir ± ribavirin in the treatment of HCV infection: The real-world HARVEST study
    Flisiak, Robert
    Lucejko, Mariusz
    Mazur, Wlodzimierz
    Janczewska, Ewa
    Berak, Hanna
    Tomasiewicz, Krzysztof
    Mozer-Lisewska, Iwona
    Kozielewicz, Dorota
    Gietka, Andrzej
    Sikorska, Katarzyna
    Wawrzynowicz-Syczewska, Marta
    Nowak, Krzysztof
    Zarebska-Michaluk, Dorota
    Musialik, Joanna
    Simon, Krzysztof
    Garlicki, Aleksander
    Plesniak, Robert
    Baka-Cwierz, Barbara
    Olszok, Iwona
    Augustyniak, Krystyna
    Stolarz, Wojciech
    Bialkowska, Jolanta
    Badurek, Anna
    Piekarska, Anna
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (02): : 387 - 392
12345